Poseida Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, after Year Five
Poseida Therapeutics, Inc. had Lessee, Operating Lease, Liability, to be Paid, after Year Five of $5.58 million as of 2023-12-31, per its 10-K filed 2024-03-07.
Discontinued › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive · last filed 2024-03-07
- 2023-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $5.58M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $11.00M.
- 2021-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $16.26M.
- 2020-12-31: Lessee, Operating Lease, Liability, to be Paid, after Year Five $20.40M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, after Year Five |
|---|---|
| 2023-12-31 | $5.58M 10-K · filed 2024-03-07 |
| 2022-12-31 | $11.00M 10-K · filed 2023-03-09 |
| 2021-12-31 | $16.26M 10-K · filed 2022-03-10 |
| 2020-12-31 | $20.40M 10-K · filed 2021-03-11 |
| 2020-06-30 | $20.31M 10-Q · filed 2020-08-20 |